JP Morgan Chase
COLL icon

JP Morgan Chase’s Collegium Pharmaceutical COLL Stock Holding History

JP Morgan Chase’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.54M Buy
110,702
+2,663
+2% +$113K ﹤0.01% 3643
2025
Q4 		$5M Sell
108,039
-103,718
-49% -$4.34M ﹤0.01% 3315
2025
Q3 		$7.41M Buy
211,757
+139,689
+194% +$4.86M ﹤0.01% 2993
2025
Q2 		$2.13M Buy
72,068
+2,592
+4% +$73.9K ﹤0.01% 3864
2025
Q1 		$2.07M Sell
69,476
-13,215
-16% -$404K ﹤0.01% 3838
2024
Q4 		$2.37M Sell
82,691
-194,513
-70% -$6.44M ﹤0.01% 4019
2024
Q3 		$10.7M Buy
277,204
+175,892
+174% +$6.27M ﹤0.01% 2543
2024
Q2 		$3.26M Sell
101,312
-24,044
-19% -$834K ﹤0.01% 3380
2024
Q1 		$4.87M Sell
125,356
-100,392
-44% -$3.51M ﹤0.01% 3133
2023
Q4 		$6.95M Buy
225,748
+81,851
+57% +$2.05M ﹤0.01% 2810
2023
Q3 		$3.22M Buy
143,897
+34,909
+32% +$796K ﹤0.01% 3177
2023
Q2 		$2.34M Sell
108,988
-18,247
-14% -$414K ﹤0.01% 3430
2023
Q1 		$3.05M Buy
127,235
+4,061
+3% +$108K ﹤0.01% 3207
2022
Q4 		$2.86M Sell
123,174
-23,774
-16% -$479K ﹤0.01% 3284
2022
Q3 		$2.35M Sell
146,948
-111,773
-43% -$1.97M ﹤0.01% 3342
2022
Q2 		$4.58M Buy
258,721
+136,736
+112% +$2.3M ﹤0.01% 2854
2022
Q1 		$2.48M Sell
121,985
-16,713
-12% -$316K ﹤0.01% 3588
2021
Q4 		$2.59M Buy
138,698
+99,191
+251% +$1.93M ﹤0.01% 3650
2021
Q3 		$780K Buy
39,507
+11,829
+43% +$256K ﹤0.01% 4475
2021
Q2 		$655K Sell
27,678
-27,143
-50% -$627K ﹤0.01% 4533
2021
Q1 		$1.3M Buy
54,821
+26,052
+91% +$619K ﹤0.01% 4023
2020
Q4 		$576K Buy
28,769
+1,648
+6% +$32.2K ﹤0.01% 4286
2020
Q3 		$539K Buy
27,121
+3,689
+16% +$66.6K ﹤0.01% 3946
2020
Q2 		$409K Buy
23,432
+4,052
+21% +$79.3K ﹤0.01% 3933
2020
Q1 		$316K Buy
19,380
+8,843
+84% +$183K ﹤0.01% 4066
2019
Q4 		$217K Hold
10,537
– – ﹤0.01% 4631
2019
Q3 		$121K Buy
10,537
+1,709
+19% +$19.5K ﹤0.01% 4823
2019
Q2 		$117K Buy
8,828
+482
+6% +$6.45K ﹤0.01% 4872
2019
Q1 		$126K Sell
8,346
-2,501
-23% -$40.1K ﹤0.01% 4812
2018
Q4 		$186K Buy
10,847
+1,705
+19% +$29.2K ﹤0.01% 4621
2018
Q3 		$135K Buy
9,142
+1,082
+13% +$19.2K ﹤0.01% 4839
2018
Q2 		$192K Sell
8,060
-78,278
-91% -$1.92M ﹤0.01% 4574
2018
Q1 		$2.21M Buy
86,338
+40,403
+88% +$963K ﹤0.01% 3205
2017
Q4 		$848K Buy
45,935
+27,516
+149% +$394K ﹤0.01% 3812
2017
Q3 		$192K Buy
+18,419
New +$203K ﹤0.01% 4118
2017
Q2 		– Sell
-2,912
Closed -$29K – 4987
2017
Q1 		$29K Buy
+2,912
New +$43.3K ﹤0.01% 4649
2016
Q3 		– Sell
-48
Closed -$1K – 4573
2016
Q2 		$1K Hold
48
– – ﹤0.01% 4664
2016
Q1 		$1K Hold
48
– – ﹤0.01% 4556
2015
Q4 		$1K Buy
+48
New +$1.01K ﹤0.01% 4582

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

JP Morgan Chase's COLL Position: Q1 2026 in Review

JP Morgan Chase increased its Collegium Pharmaceutical (COLL) stake by 2.5% in Q1 2026, buying an estimated $113K and bringing the position to 110,702 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3643.

JP Morgan Chase first reported a position in COLL in Q4 2015 and has held it in 39 quarters since. The position peaked at $10.7M in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • JP Morgan Chase held 110,702 shares of Collegium Pharmaceutical worth $3.54M as of Q1 2026.
  • JP Morgan Chase bought 2,663 Collegium Pharmaceutical shares in Q1 2026, an estimated $113K.
  • Collegium Pharmaceutical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3643 holding.
  • JP Morgan Chase first reported a position in Collegium Pharmaceutical in Q4 2015 and has held it in 39 quarters since.
  • JP Morgan Chase's Collegium Pharmaceutical position peaked at $10.7M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.